97
PATHOPHYSIOLOGY AND MANAGEMENT OF TINNITUS: A COMPLEX AND
CHALLENGING CONDITION
Urinova Shahnoza Sharifovna
Assistant at the Alfraganus University
Email: shaxnozaurinova1@gmail.com
https://doi.org/10.5281/zenodo.14523433
Abstract:
Tinnitus is the perception of sound near the head in the absence of any
external auditory source. It is estimated to affect 15–20% of the global population, with 1–3%
experiencing severe cases that significantly impair quality of life. Severe tinnitus is often
linked to depression, anxiety, and insomnia. Various risk factors, such as prolonged noise
exposure, head and neck trauma, and infections, have been identified. The most recent
pathophysiological theory suggests that the central nervous system acts as the primary
"generator" of tinnitus. Despite this, treatment approaches focus on reducing the awareness
of tinnitus and its impact on daily life rather than achieving a definitive cure. Currently, no
drug has proven effective in providing long-term relief beyond placebo effects. However, the
market for such treatments is valued at approximately $1.1 billion, with potential for growth
as the global population ages. This review explores the latest developments in the
understanding and management of tinnitus, which continues to be a chronic and debilitating
condition.
Keywords
: Tinnitus, Pathophysiology, Treatment.
Introduction
Tinnitus, derived from the Latin word
tinnire
("to ring"), refers to the perception of
sound near the head without any external auditory source. It can be described as buzzing,
ringing, roaring, whistling, or hissing, and its characteristics can vary greatly. Tinnitus may be
intermittent, continuous, or pulsatile, with pulsatile tinnitus often being particularly
bothersome and distressing. It is estimated that 15–20% of the global population experiences
tinnitus, and for about 25% of those affected, it disrupts daily activities. In 1–3% of cases,
tinnitus severely impacts quality of life. Severe tinnitus is commonly associated with
depression, anxiety, and insomnia.
Throughout the second half of the 20th century, numerous theories regarding the cause
of tinnitus were proposed, and various treatment approaches, including medications and
surgical interventions, were developed with mixed results [6]. Despite these advances,
tinnitus remains a debilitating condition with no definitive cure, and in extreme cases, it has
led to suicidal thoughts or actions.
Classification
Tinnitus can be categorized into two types: objective and subjective. Objective tinnitus
involves the generation of noise near the ear that can sometimes be heard by an examiner
using a stethoscope. Subjective tinnitus, on the other hand, is the perception of sound in the
absence of an acoustic stimulus, and it is heard only by the patient.
Objective tinnitus is rare and typically presents as a pulsatile sound, which can be
caused by turbulent blood flow through the carotid artery or jugular vein. It may also be
associated with highly vascular middle ear tumors, such as glomus jugulare tumors, or dural
arteriovenous malformations.
98
Subjective tinnitus is much more common and can occur with nearly any ear disorder.
Frequent causes include sensorineural hearing loss (e.g., from acoustic trauma), ear canal
obstruction due to cerumen, infections like otitis media, Eustachian tube dysfunction, and
medications such as salicylates. The majority of patients experience sensorineural tinnitus,
which is linked to hearing loss at the cochlear or cochlear nerve level.
Pathophysiology
Tinnitus has been linked to various risk factors, including prolonged noise exposure
(accounting for 22% of cases), head and neck injuries (17% of cases), and infections (10% of
cases). The most recent pathophysiological theory proposes that the central nervous system
acts as the primary source, or "generator," of tinnitus. Studies using positron emission
tomography (PET) and functional magnetic resonance imaging (fMRI) have shown that a loss
of cochlear input to neurons in the central auditory system—such as from cochlear hair cell
damage or lesions in the vestibulocochlear nerve—can trigger abnormal neural activity in the
auditory cortex. This abnormal activity is thought to be associated with the perception of
tinnitus. Additionally, there is a loss of suppression in the neural feedback loops that help
fine-tune and reinforce auditory memory in the central auditory cortex. Disruption of these
feedback mechanisms leads to the disinhibition of normal synapses and the formation of
uncontrolled alternative neural synapses, which contribute to the distorted auditory
perception of tinnitus. Recent advancements in neuro-otometry have provided deeper
insights into the complex pathophysiological mechanisms underlying tinnitus, identifying
specific areas where these processes occur. It is now understood that approximately 24% of
tinnitus cases are linked to abnormalities in the otoacoustic periphery (i.e., the inner ear and
vestibulocochlear nerve), 35% arise from issues within the acoustic pathways, and 41% are
attributed to causes in supratentorial structures. A disruption in the balance between
inhibition and excitation can lead to an excitatory-inhibitory imbalance, resulting in neuronal
hyperexcitability in these regions and the perception of tinnitus. Additionally, neuronal
excitability can be influenced by various neurotransmitters and neuromodulators that act on
voltage- or ligand-gated channels, offering potential pharmacological targets for treatment.
Treatment
Given that tinnitus is associated with significant irritability, agitation, stress, depression,
insomnia, and disruption of daily life, even a small but meaningful effect from a drug could
provide considerable therapeutic benefit. However, due to the variety of potential causes and
the complex pathophysiological mechanisms involved, a definitive treatment for tinnitus has
yet to be developed. Currently, there is no FDA or European Medicines Agency (EMEA)-
approved drug specifically for tinnitus. No drug studied in the literature has shown consistent,
long-term reduction in tinnitus impact beyond placebo effects. The current treatment strategy
focuses on managing underlying conditions and symptomatically reducing the perception of
tinnitus. The primary goal is to improve quality of life, rather than achieving a complete cure.
Various regimens are used, although none demonstrate full efficacy.
Comprehensive management of tinnitus includes evaluating conditions such as
hypertension, blood lipid levels, thyroid function, and allergies, as well as educating patients
about factors that exacerbate tinnitus, such as stress, caffeine, nicotine, and aspirin. Treatment
of comorbidities may include procedures like embolization or ligation for vascular issues,
such as arteriovenous malformations. Hearing aids for presbycusis, cochlear implants for
99
sensorineural hearing loss, and discontinuation of offending medications are also key aspects
of care.
Many tinnitus patients show signs of anxiety or depression, which are linked to elevated
serotonin levels. Serotonin and GABA receptors are found throughout the auditory system,
and neurotransmitter imbalances may contribute to symptoms in some cases. Symptomatic
relief has been sought through medications such as antidepressants (e.g., amitriptyline),
anxiolytics (e.g., diazepam), anticonvulsants (e.g., clonazepam), diuretics, and antihistamines
(e.g., dexchlorpheniramine maleate), though results have been inconsistent and inconclusive.
Tinnitus-specific medications have also been largely ineffective. Trials involving
prostaglandin E1 analogue misoprostol, gabapentin, lidocaine, and dexamethasone have
shown only limited benefits. Complementary and alternative medicine (CAM) therapies, such
as Ginkgo biloba, the most common CAM treatment, have not yielded definitive results in
large trials.
On the other hand, several non-medical treatments have shown some success. These
include tinnitus retraining therapy (TRT), masking, biofeedback, and cognitive behavioral
therapy.
TRT aims to bypass or override abnormal auditory cortex neural connections, which are
thought to drive tinnitus. It operates on the principle that all levels of the auditory pathways
are involved in tinnitus and promotes habituation to the tinnitus signal. The goal is for
patients to become unaware of their tinnitus unless they consciously focus on it. This
habituation is achieved through directive counseling combined with low-level noise from
wearable generators and environmental sounds. Significant improvements have been
reported in up to 80% of patients, but well-controlled studies are limited, the long-term
effects are unknown, and the therapy often takes one to two years to show results.
Masking devices produce low-level sounds to reduce tinnitus perception. While these
devices are beneficial for some patients, they are not universally effective, and some
individuals have reported worsening of their tinnitus.
Conclusion
Tinnitus can originate at various points along the auditory pathway, from the cochlear
nucleus to the auditory cortex. Leading theories suggest it may result from damaged cochlear
hair cells that continuously stimulate auditory nerve fibers, spontaneous activity in individual
auditory nerve fibers, hyperactivity of auditory nuclei in the brainstem, or a reduction in the
normally suppressive activity of the central auditory cortex on peripheral auditory nerve
signals.
Despite progress in understanding the pathophysiology of tinnitus, current treatment
approaches primarily focus on reducing awareness of the condition and minimizing its impact
on quality of life, rather than offering a definitive cure. No drug has yet shown consistent,
long-term reduction in tinnitus effects beyond placebo responses. Medical treatments have
proven limited in efficacy and reliability, underscoring the need for further research into non-
medical therapies such as tinnitus retraining therapy (TRT), cognitive behavioral therapy, and
masking techniques. As a result, tinnitus remains a chronic and often debilitating condition for
many patients. However, advancements in molecular, biochemical, and imaging technologies
are providing valuable insights into the underlying causes of tinnitus, paving the way for the
development of new potential treatment targets.
100
References:
1.
Crummer RW, Hassan GA. Diagnostic approach to tinnitus.
Am Fam Physician
.
2004;69(1):120–126. [PubMed] [Google Scholar]
2.
Coles RR. Epidemiology of tinnitus: (1) prevalence.
J Laryngol Otol Suppl
. 1984;9:7–15.
doi: 10.1017/S1755146300090041. [DOI] [PubMed] [Google Scholar]
3.
Axelsson A, Ringdahl A. Tinnitus–a study of its prevalence and characteristics.
Br J
Audiol
. 1989;23(1):53–62. doi: 10.3109/03005368909077819. [DOI] [PubMed] [Google
Scholar]
4.
Cronlein T, Langguth B, Geisler P, Hajak G. Tinnitus and insomnia.
Prog Brain Res
.
2007;166:227–233. doi: 10.1016/S0079-6123(07)66021-X. [DOI] [PubMed] [Google Scholar]
5.
Langguth B, Kleinjung T, Fischer B, Hajak G, Eichhammer P, Sand PG. Tinnitus severity,
depression, and the big five personality traits.
Prog Brain Res
. 2007;166:221–225. doi:
10.1016/S0079-6123(07)66020-8. [DOI] [PubMed] [Google Scholar]
6.
Claussen CF.
Rakel & Bope: Conn’s Current Therapy
. 60. Philadelphia: Elsevier Inc.; 2008.
[Google Scholar]
7.
Jacobson GP, McCaslin DL. A search for evidence of a direct relationship between
tinnitus and suicide.
J Am Acad Audiol
. 2001;12(10):493–496. [PubMed] [Google Scholar]
8.
Lockwood
AH.
Tinnitus.
Neurol
Clin
.
2005;23(3):893–900.
doi:
10.1016/j.ncl.2005.01.007. [DOI] [PubMed] [Google Scholar]
9.
Ahmad N, Seidman M. Tinnitus in the older adult: epidemiology, pathophysiology and
treatment options.
Drugs Aging
. 2004;21(5):297–305. doi: 10.2165/00002512-200421050-
00002. [DOI] [PubMed] [Google Scholar]
10.
Lockwood AH, Salvi RJ, Burkard RF, Galantowicz PJ, Coad ML, Wack DS. Neuroanatomy
of tinnitus.
Scand Audiol Suppl
. 1999;51:47–52. [PubMed] [Google Scholar]
11.
Shulman A, Goldstein B. Medical significance of tinnitus.
Int Tinnitus J
. 1997;3(1):45–50.
[PubMed] [Google Scholar]
